Nexium Capsules S-CEI for Justification of Esomeprazole in Acid Related Disease for Reflux Symptom Healing Based on Patient Clinical Outcomes
NCT02477475 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1595
Last updated 2017-06-21
Summary
The objective of this investigation is to collect following data in patients given NEXIUM capsule (NEXIUM) in usual post-marketing use.
Conditions
- Reflux Esophagitis
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Shigeru Yoshida, MD · AstraZeneca
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-07-07
- Primary Completion
- 2017-02-20
- Completion
- 2017-02-20
Countries
- Japan
Study Locations
More Related Trials
-
Acid Reflux and Stromal Fibroblasts in Barrett's Esophagus
NCT00573911 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy of TAK-438 Compared to AG-1749 (Lansoprazole) in the Maintenance Treatment of Healed Erosive Esophagitis
NCT01459367 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Safety and Efficacy of X842 in Patients With Reflux Esophagitis
NCT04531475 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Esomeprazole Once Daily for the Treatment of GERD in Neonatal Patients
NCT00427635 ·Status: COMPLETED ·Phase: PHASE3
-
Survey to Describe Impact of Reflux Disease on Everyday Life in GERD Patients Before and After 4 Weeks Treatment.
NCT00786773 ·Status: COMPLETED
-
Efficacy and Safety of Dexlansoprazole MR on Maintaining Healing in Subjects With Healed Erosive Esophagitis
NCT00255164 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Dexlansoprazole Delayed-Release Capsules for Healing of Erosive Esophagitis and Maintenance of Healed Erosive Esophagitis and Relief of Heartburn in Adolescents
NCT01642615 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Dexlansoprazole MR to Placebo on the Ability to Maintain Healing in Subjects With Healed Erosive Esophagitis
NCT00255151 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of E3810 With Pre- and Post-Treatment pH Monitoring in Patients With Non-Erosive Gastroesophageal Reflux Disease
NCT00165672 ·Status: COMPLETED ·Phase: PHASE3
-
Quality of Life in New Treatable Therapy as Rabeprazole Option for Refractory Reflux Esophagitis
NCT01321567 ·Status: COMPLETED
-
The Effect of Probiotic and Zinc Supplementation in Patients With Gastroesophageal Reflux Disease
NCT06664008 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Rabeprazole in Subjects With Gastroesophageal Reflux Disease (GERD)
NCT00222170 ·Status: COMPLETED ·Phase: PHASE2
-
High Dosage Esomeprazole and Baclofen for Therapy of Gastroesophageal Reflux Disease
NCT00461604 ·Status: COMPLETED
-
A Study to Check the Safety of Dexlansoprazole and Learn If it Can Heal Erosive Esophagitis (EE) and Keep it Healed in Children 2 to 11 Years Old
NCT02615184 ·Status: TERMINATED ·Phase: PHASE2
-
Open, Randomised, Multi-center Study of on Demand Versus Continuous Esomeprazole Treatment in Patient With GERD
NCT02670642 ·Status: COMPLETED ·Phase: PHASE3
-
The Primary Symptoms of GERD(Gastroesophageal Reflux Disease) in Chinese Outpatients in Gastroenterology Department
NCT02506634 ·Status: COMPLETED
-
Efficacy and Safety of Dexlansoprazole MR Compared to Placebo on Maintaining Healing in Subjects With Healed Erosive Esophagitis
NCT00321737 ·Status: COMPLETED ·Phase: PHASE3
-
Predictors of Proton Pump Inhibitor (PPI) Response in Eosinophilic Esophagitis
NCT01479231 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Phase 3/Safety & Efficacy of Esomeprazole in Infants
NCT00468559 ·Status: COMPLETED ·Phase: PHASE3
-
Study Using Esomeprazole as a Diagnostic Test for GERD in Patients With NCCP
NCT00786695 ·Status: COMPLETED ·Phase: NA
-
Symptom Improvements in Gastroesophageal Reflux Disease (GERD) Patients
NCT00394472 ·Status: COMPLETED ·Phase: PHASE2
-
Minimal Change Esophagitis by i-Scan Endoscopy in Dyspeptic Patients
NCT01742377 ·Status: COMPLETED
-
Symptom Adapted Therapy in GERD Patients
NCT00343161 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Acid Reflux at Two Levels in the Esophagus Using the BRAVO Capsule
NCT00579410 ·Status: COMPLETED
-
A Study to Estimate Effect of 4 Different Doses of AZD3355 on Reflux Episodes, Which Patients With Gastroesophageal Reflux Disease (GERD) May Experience
NCT01043185 ·Status: COMPLETED ·Phase: PHASE2